Search research articles
Contact Us
Filters
Showing results (641-650 of 1,117) with videos related to
Page
of 112
Sort By:
European Journal of Cancer (Oxford, England : 1990)
|
September 23, 2025
<sup>177</sup>Lu-PSMA vs. cabazitaxel in patients with castration-resistant prostate cancer: Real-world efficacy and safety data from the ARON-3 study
Philipp Mandel, Daniel Groener, Giulia Follacchio, et al.
Cancer Immunology, Immunotherapy : CII
|
February 3, 2026
Effectiveness of ICI-ICI versus ICI-TKI combinations in patients with IMDC intermediate- and poor-risk metastatic renal cell carcinoma: a sub-analysis of the MEET-URO 33 study
Michele Maffezzoli, Alessio Signori, Alessandro Acunzo, et al.
European Urology Oncology
|
June 26, 2025
PERSEUS1: An Open-label, Investigator-initiated, Single arm, Phase 2 Trial Testing the Efficacy of Pembrolizumab in Patients with Metastatic Castration-resistant Prostate Cancer with Mismatch Repair Deficiency and Other Immune-sensitive Molecular Subtypes
Pasquale Rescigno, Maria Dolores Fenor de la Maza, Holly Tovey, et al.
Plos One
|
May 7, 2024
Impact of liver fibrosis on COVID-19 in-hospital mortality in Southern Italy
Raffaele Galiero, Giuseppe Loffredo, Vittorio Simeon, et al.
Iscience
|
October 20, 2023
Using peripheral immune-inflammatory blood markers in tumors treated with immune checkpoint inhibitors: An INVIDIa-2 study sub-analysis
Shobana Anpalakhan, Alessio Signori, Alessio Cortellini, et al.
Minerva Urology and Nephrology
|
June 23, 2026
Darolutamide versus abiraterone acetate-based triplets in patients with hormone-sensitive prostate cancer: real-world, head-to-head comparison from the ARON-3 study
Pasquale Rescigno, Tarek Taha, Maria J Fita, et al.
Journal of Clinical Medicine
|
October 27, 2022
Association between Renal Function at Admission and COVID-19 in-Hospital Mortality in Southern Italy: Findings from the Prospective Multicenter Italian COVOCA Study
Raffaele Galiero, Vittorio Simeon, Giuseppe Loffredo, et al.
European Urology Oncology
|
November 29, 2024
Apalutamide in Metastatic Castration-sensitive Prostate Cancer: Results from the Multicenter Real-world ARON-3 Study
Matteo Santoni, Thomas Büttner, Pasquale Rescigno, et al.
Cancer Cell
|
September 20, 2024
Coagulation factor X promotes resistance to androgen-deprivation therapy in prostate cancer
Bianca Calì, Martina Troiani, Silvia Bressan, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
May 8, 2019
Genomic correlates of clinical outcome in advanced prostate cancer
Wassim Abida, Joanna Cyrta, Glenn Heller, et al.
Page
of 112
Search research articles
Search
Showing results (641-650 of 1,117) with videos related to
Sort By:
Page
of 112
European Journal of Cancer (Oxford, England : 1990)
|
September 23, 2025
<sup>177</sup>Lu-PSMA vs. cabazitaxel in patients with castration-resistant prostate cancer: Real-world efficacy and safety data from the ARON-3 study
Philipp Mandel, Daniel Groener, Giulia Follacchio, et al.
Cancer Immunology, Immunotherapy : CII
|
February 3, 2026
Effectiveness of ICI-ICI versus ICI-TKI combinations in patients with IMDC intermediate- and poor-risk metastatic renal cell carcinoma: a sub-analysis of the MEET-URO 33 study
Michele Maffezzoli, Alessio Signori, Alessandro Acunzo, et al.
European Urology Oncology
|
June 26, 2025
PERSEUS1: An Open-label, Investigator-initiated, Single arm, Phase 2 Trial Testing the Efficacy of Pembrolizumab in Patients with Metastatic Castration-resistant Prostate Cancer with Mismatch Repair Deficiency and Other Immune-sensitive Molecular Subtypes
Pasquale Rescigno, Maria Dolores Fenor de la Maza, Holly Tovey, et al.
Plos One
|
May 7, 2024
Impact of liver fibrosis on COVID-19 in-hospital mortality in Southern Italy
Raffaele Galiero, Giuseppe Loffredo, Vittorio Simeon, et al.
Iscience
|
October 20, 2023
Using peripheral immune-inflammatory blood markers in tumors treated with immune checkpoint inhibitors: An INVIDIa-2 study sub-analysis
Shobana Anpalakhan, Alessio Signori, Alessio Cortellini, et al.
Minerva Urology and Nephrology
|
June 23, 2026
Darolutamide versus abiraterone acetate-based triplets in patients with hormone-sensitive prostate cancer: real-world, head-to-head comparison from the ARON-3 study
Pasquale Rescigno, Tarek Taha, Maria J Fita, et al.
Journal of Clinical Medicine
|
October 27, 2022
Association between Renal Function at Admission and COVID-19 in-Hospital Mortality in Southern Italy: Findings from the Prospective Multicenter Italian COVOCA Study
Raffaele Galiero, Vittorio Simeon, Giuseppe Loffredo, et al.
European Urology Oncology
|
November 29, 2024
Apalutamide in Metastatic Castration-sensitive Prostate Cancer: Results from the Multicenter Real-world ARON-3 Study
Matteo Santoni, Thomas Büttner, Pasquale Rescigno, et al.
Cancer Cell
|
September 20, 2024
Coagulation factor X promotes resistance to androgen-deprivation therapy in prostate cancer
Bianca Calì, Martina Troiani, Silvia Bressan, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
May 8, 2019
Genomic correlates of clinical outcome in advanced prostate cancer
Wassim Abida, Joanna Cyrta, Glenn Heller, et al.
Page
of 112